General Information
Drug ID
DR00480
Drug Name
Cyclacillin
Synonyms
(1-Aminocyclohexyl)penicillin; (2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-(8CI); 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)penicillanic acid; 6-(1-Aminocyclohexylcarboxamido)penicillanic acid; 6beta-(1-aminocyclohexanecarboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid; AC 98; Aminocyclohexyl penicillin; Aminocyclohexylpenicillin; Bastcillin; C-12104; Calthor; Ciclacilina; Ciclacilina [INN-Spanish]; Ciclacillin; Ciclacillin (JP15/INN); Ciclacilline; Ciclacilline [INN-French]; Ciclacillinum; Ciclacillinum [INN-Latin]; Ciclacillum; Citosarin; Cyclacillin (USAN); Cyclacillin [USAN]; Cyclapen; Cyclapen (TN); Cyclapen-W; Cyclapen-W (TN); Noblicil; Orfilina; Peamezin; Syngacillin; Ultracillin; Vastcillin; Vastcillin (TN); Vipicil; WY 4508; WY4508; Wy-4508; Wyvital
Drug Type
Small molecular drug
Indication Bacterial infections [ICD11: 1A00-1H0Z] Approved [1]
Therapeutic Class
Antibiotics
Structure
3D MOL 2D MOL
Formula
C15H23N3O4S
Canonical SMILES
CC1(C(N2C(S1)C(C2=O)NC(=O)C3(CCCCC3)N)C(=O)O)C
InChI
InChI=1S/C15H23N3O4S/c1-14(2)9(12(20)21)18-10(19)8(11(18)23-14)17-13(22)15(16)6-4-3-5-7-15/h8-9,11H,3-7,16H2,1-2H3,(H,17,22)(H,20,21)/t8-,9+,11-/m1/s1
InChIKey
HGBLNBBNRORJKI-WCABBAIRSA-N
CAS Number
CAS 3485-14-1
Pharmaceutical Properties Molecular Weight 341.4 Topological Polar Surface Area 138
Heavy Atom Count 23 Rotatable Bond Count 3
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 6
XLogP
1.3
PubChem CID
19003
PubChem SID
103770339 , 103914475 , 104346698 , 11112536 , 11446317 , 11467148 , 11468268 , 11486856 , 124766183 , 128055795 , 134224408 , 134338404 , 134985468 , 136357160 , 137012596 , 137178974 , 144204085 , 15075673 , 160964336 , 162516292 , 178101519 , 179149343 , 198937842 , 226420447 , 29286625 , 396250 , 46508073 , 47291276 , 47365368 , 47440419 , 48259416 , 48415821 , 49699306 , 49956857 , 50123946 , 57269579 , 57330251 , 583155 , 602914 , 74457515 , 7848397 , 8139302 , 8164183 , 85788579 , 92126086
ChEBI ID
ChEBI:31444
TTD Drug ID
D00HWO
DT(s) Transporting This Drug PEPT1 Transporter Info Peptide transporter 1 Substrate [2]
PEPT2 Transporter Info Peptide transporter 2 Substrate [2]
References
1 Cyclacillin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Transport characteristics of a novel peptide transporter 1 substrate, antihypotensive drug midodrine, and its amino acid derivatives. J Pharmacol Exp Ther. 2006 Jul;318(1):455-60.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.